AU2010233926B2 - Biomarkers, methods and kits for the diagnosis of Rheumatoid Arthritis - Google Patents

Biomarkers, methods and kits for the diagnosis of Rheumatoid Arthritis Download PDF

Info

Publication number
AU2010233926B2
AU2010233926B2 AU2010233926A AU2010233926A AU2010233926B2 AU 2010233926 B2 AU2010233926 B2 AU 2010233926B2 AU 2010233926 A AU2010233926 A AU 2010233926A AU 2010233926 A AU2010233926 A AU 2010233926A AU 2010233926 B2 AU2010233926 B2 AU 2010233926B2
Authority
AU
Australia
Prior art keywords
seq
biomarker
peptides
braf
pad4
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2010233926A
Other languages
English (en)
Other versions
AU2010233926A1 (en
Inventor
Isabelle Auger
Jean Roudier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aix-Marseille Université
Institut National de la Santé et de la Recherche Médicale
Original Assignee
Aix-Marseille Université
Institut National de la Santé et de la Recherche Médicale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aix-Marseille Université, Institut National de la Santé et de la Recherche Médicale filed Critical Aix-Marseille Université
Publication of AU2010233926A1 publication Critical patent/AU2010233926A1/en
Application granted granted Critical
Publication of AU2010233926B2 publication Critical patent/AU2010233926B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/8139—Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/11—Protein-serine/threonine kinases (2.7.11)
    • C12Y207/11001—Non-specific serine/threonine protein kinase (2.7.11.1), i.e. casein kinase or checkpoint kinase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y305/00—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
    • C12Y305/03—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in linear amidines (3.5.3)
    • C12Y305/03015—Protein-arginine deiminase (3.5.3.15)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G01N2800/102—Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Rheumatology (AREA)
  • Rehabilitation Therapy (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
AU2010233926A 2009-03-30 2010-03-29 Biomarkers, methods and kits for the diagnosis of Rheumatoid Arthritis Ceased AU2010233926B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP09305266 2009-03-30
EP09305266.0 2009-03-30
EP09306063.0 2009-11-06
EP09306063 2009-11-06
PCT/EP2010/054087 WO2010115745A2 (en) 2009-03-30 2010-03-29 Biomarkers, methods and kits for the diagnosis of rheumatoid arthritis

Publications (2)

Publication Number Publication Date
AU2010233926A1 AU2010233926A1 (en) 2011-09-08
AU2010233926B2 true AU2010233926B2 (en) 2014-01-16

Family

ID=42315391

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2010233926A Ceased AU2010233926B2 (en) 2009-03-30 2010-03-29 Biomarkers, methods and kits for the diagnosis of Rheumatoid Arthritis

Country Status (7)

Country Link
US (2) US9267946B2 (enExample)
EP (1) EP2414836B1 (enExample)
JP (2) JP5728743B2 (enExample)
AU (1) AU2010233926B2 (enExample)
CA (1) CA2756073A1 (enExample)
ES (1) ES2483724T3 (enExample)
WO (1) WO2010115745A2 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0708585D0 (en) 2007-05-03 2007-06-13 Queen Mary & Westfield College Novel antibody and use in diagnosis and therapy of arthropathies
CA2835477A1 (en) 2011-05-13 2012-11-22 Inserm (Institut National De La Sante Et De La Recherche Medicale) Method for the diagnosis of early rheumatoid arthritis
EP2527841A1 (en) 2011-05-25 2012-11-28 Toscana Biomarkers S.r.l. Methods for the diagnosis of rheumatoid arthritis
US20130274125A1 (en) * 2012-04-16 2013-10-17 Bio-Rad Laboratories Inc. Multiplex immunoassay for rheumatoid arthritis and other autoimmune diseases
GB201302036D0 (en) * 2013-02-05 2013-03-20 Queen Mary & Westfield College Diagnosis
KR101664966B1 (ko) * 2013-06-21 2016-10-11 가톨릭대학교 산학협력단 류마티스 관절염 활성도 평가용 바이오마커
US9829493B2 (en) 2013-07-15 2017-11-28 Steven J. Svoboda Methods and apparatus for assessment of risk for joint injury
GB201603462D0 (en) * 2016-02-29 2016-04-13 Ge Healthcare Uk Ltd Ethylene oxide treatment
WO2017202879A1 (en) * 2016-05-24 2017-11-30 Medimmune Limited Anti-pad4 autoantibodies as clinical response biomarkers for the treatment of rheumatoid arthritis
CN106950365B (zh) * 2017-02-15 2018-11-27 中国医学科学院北京协和医院 一种acpa阴性的ra诊断标志物及其应用
CN107290539B (zh) * 2017-06-07 2019-06-07 哈尔滨医科大学 用于检测自身免疫病患者血清标志物的多肽组合物及其应用
EA033501B1 (ru) * 2018-04-03 2019-10-31 Obschestvo S Ogranichennoj Otvetstvennostyu Nauchno Proizvodstvennaya Firma Abris Способ дифференциальной диагностики ранней или выраженной стадии ревматоидного артрита с остеоартритом
WO2020178426A1 (en) * 2019-03-07 2020-09-10 INSERM (Institut National de la Santé et de la Recherche Médicale) New vaccinal strategy to prevent or treat rheumatoid arthritis
WO2021231879A1 (en) * 2020-05-15 2021-11-18 Inova Diagnostics, Inc. Compositions and methods for diagnosing and assessing rheumatoid arthritis using protein-arginine deiminase 1 (pad1) autoantigens
CN118240057B (zh) * 2024-05-28 2024-07-23 北京大学人民医院 一种抗原肽及其在制备类风湿关节炎诊断产品中的应用

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000009709A2 (en) * 1998-08-10 2000-02-24 Incyte Pharmaceuticals, Inc. Proteases and associated proteins
WO2003050141A2 (en) * 2001-12-10 2003-06-19 Institute Of Enzimology, Biological Research Center Of The Hungarian Academy Of Sciences Calpain activators
JP2003254966A (ja) * 2002-02-28 2003-09-10 Seikagaku Kogyo Co Ltd 抗カルパスタチン抗体の測定法及び測定キット
WO2004020595A2 (en) * 2002-08-29 2004-03-11 Five Prime Therapeutics, Inc. Novel human polypeptides encoded by polynucleotides
WO2004065633A1 (ja) * 2003-01-21 2004-08-05 Riken ペプチジルアルギニン・デイミナーゼ・タイプⅳの利用方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4208479A (en) * 1977-07-14 1980-06-17 Syva Company Label modified immunoassays
US5705400A (en) * 1992-03-07 1998-01-06 Rsr Limited Assay for adrenal autoantigen
JPWO2005075414A1 (ja) * 2004-02-04 2007-10-11 公立大学法人横浜市立大学 ペプチジルアルギニンデイミナーゼ４阻害剤
US20070148704A1 (en) * 2005-10-06 2007-06-28 Ursula Klause Anti-CCPand antinuclear antibodies in diagnosis of rheumatoid arthritis
US20090176664A1 (en) * 2007-06-01 2009-07-09 Keting Chu High density peptide arrays containing kinase or phosphatase substrates

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000009709A2 (en) * 1998-08-10 2000-02-24 Incyte Pharmaceuticals, Inc. Proteases and associated proteins
WO2003050141A2 (en) * 2001-12-10 2003-06-19 Institute Of Enzimology, Biological Research Center Of The Hungarian Academy Of Sciences Calpain activators
JP2003254966A (ja) * 2002-02-28 2003-09-10 Seikagaku Kogyo Co Ltd 抗カルパスタチン抗体の測定法及び測定キット
WO2004020595A2 (en) * 2002-08-29 2004-03-11 Five Prime Therapeutics, Inc. Novel human polypeptides encoded by polynucleotides
WO2004065633A1 (ja) * 2003-01-21 2004-08-05 Riken ペプチジルアルギニン・デイミナーゼ・タイプⅳの利用方法

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
Auger, I. et al., Annals of the Rheumatic Diseases, published online October 28 2008, Vol. 68, pages 591-594 *
Halvorsen, E. H. et al., Annals of the Rheumatic Diseases, 2008, Vol. 67, pages 414-417 *
Harris, M. L. et al, Arthritis & Rheumatism, 2008, Vol. 58, No. 7, pages 1958-1967 *
Zhao, J. et al., The Journal of Rheumatology, 2008, Vol. 35, No. 6, pages 969-974 *

Also Published As

Publication number Publication date
JP5728743B2 (ja) 2015-06-03
JP2012522232A (ja) 2012-09-20
EP2414836B1 (en) 2014-05-07
WO2010115745A3 (en) 2010-12-16
CA2756073A1 (en) 2010-10-14
US20120083423A1 (en) 2012-04-05
EP2414836A2 (en) 2012-02-08
US9267946B2 (en) 2016-02-23
WO2010115745A2 (en) 2010-10-14
ES2483724T3 (es) 2014-08-07
JP2015135340A (ja) 2015-07-27
AU2010233926A1 (en) 2011-09-08
US20160153983A1 (en) 2016-06-02

Similar Documents

Publication Publication Date Title
US9267946B2 (en) Biomarkers, methods and kits for the diagnosis of rheumatoid arthritis
JP5663723B2 (ja) 関節リウマチの診断のための方法およびキット
KR101067817B1 (ko) Ａｉｍｐ1 폴리펩티드에 대한 항체를 포함하는 관절염 진단용 조성물
US20120046181A1 (en) Biomarkers for the Diagnosis of Renal Allograft and Kidney Status
JP2009505049A (ja) 関節リウマチにおいて形成される自己抗体を検出するための方法
US20150133322A1 (en) Method for the diagnosis of early rheumatoid arthritis
CA2814026C (en) Moesin fragments associated with aplastic anemia
US20150185226A1 (en) Method for Diagnosing Scleroderma
CN101282989A (zh) 用于诊断风湿性疾病的方法
WO2012045279A1 (en) Moesin fragments associated with immune thrombocytopenia
KR20020021813A (ko) 이성질화된/임의로 반전된 에피토프에 대한 특이성자가면역 반응: 자가면역 질환 진단의 응용
US7812125B2 (en) Cartilage intermediate layer protein 2 C1 and its use to differentiate osteoarthritis from rheumatoid arthritis and non-disease conditions
US20190195871A1 (en) Diagnosis Method for Lupus
CN115605758A (zh) 使用蛋白质-精氨酸脱亚胺酶1(pad1)自身抗原诊断和评估类风湿性关节炎的组合物和方法
WO2003100426A1 (en) Diagnostic indicator of sjögren's syndrome
HK1124345A (en) Method for diagnosing rheumatic diseases

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired